Drug Evaluation Committee Introduction and modeling of NICE TSD Evidence collection and review for model creation

Data Science Subcommittee

November 2021

With the formal introduction of cost-effectiveness evaluation into the NHI drug pricing system in 2019, we believe that the keyword "health economic evaluation" is becoming more prevalent in Japan among those in charge of data science and those in charge of drug pricing and external relations closer to the authorities, such as the Chuikyo Medical Association. The Data Science Subcommittee's FY2021 Continuing Task Force 3 is working on "Organizing and Introducing Statistical Methods Related to Health Economic Evaluation," and this report introduces technical papers published by the National Institute for Health and Care Excellence (NICE) of the United Kingdom, which was an early adopter of cost-effectiveness evaluation. This report explains how to create a disease model for health economic evaluation and how to efficiently create the evidence necessary for the model, based on TSD13 of the Technical Support Document (TSD) published by the National Institute for Health and Care Excellence (NICE) in the U.K., which is an early adopter of cost-effectiveness evaluation. The book explains how to create a disease model for health economic evaluation and how to efficiently create the evidence necessary for the model.
When conducting health economic evaluation, it is common practice to create models that describe the process of a disease. The advantages of creating a model include the ability to evaluate multiple lines of evidence and to simulate outcomes under different circumstances (e.g., severity of disease, medical environment). We hope that this report will help you understand existing models as well as how to create new appropriate models, and help you to utilize models more effectively.

Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
Data Science Subcommittee 2021 Ongoing Task Force 3

Introduction to NICE TSD and Model Creation - Collection and Review of Evidence for Model Creation (4.3MB)

Share this page

TOP